A study in migraine sufferers using B group vitamins in a double-blind placebo controlled study to determine effective doses for reduction of migraine morbidity.

Griffith University0 个研究点目标入组 400 人开始时间: 2012年11月13日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•18 to 65 years of age.
•Male or female.
•Have a diagnosis of migraine with aura according to International Headache Society Criteria
•Participants with adequate venous access in their left and right arms to allow collection of a number of blood samples via venepuncture
•Fluent in the English language.
•Have voluntarily given written informed consent to participate in this study.

•Other definable cause for clinical presentation (i.e. not migraine).
•Other severe illness or use of medication that might interfere with assessment or hamper patients ability to complete the study.
•History of any psychiatric illness which may impair the ability to provide written informed consent.
•Poor compliers or those unlikely to attend.
•Participation in a clinical trial, or has received any experimental therapy, within the last 30 days.
•Donated or lost a significant amount of blood (e.g. 550 mL) within the past 12 weeks.
•Persons already taking vitamin B supplementation

发起方